Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer

被引:43
作者
Guo, Jing [1 ,2 ]
Chen, Shangxiang [1 ,2 ]
Chen, Yongming [1 ,2 ]
Li, Shun [1 ,2 ]
Xu, Dazhi [1 ,2 ]
机构
[1] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Gastr Surg, Canc Ctr, 651 East Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China
关键词
inflammation index; NLR; CRP; combination; prognosis; gastric cancer; REACTIVE PROTEIN/ALBUMIN RATIO; CURATIVE RESECTION; INFLAMMATION; PROTEIN; GASTRECTOMY; LYMPHOCYTE; NEUTROPHIL; PROGNOSIS; INDEX;
D O I
10.2147/CMAR.S156071
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: C-reactive protein (CRP) and neutrophil to lymphocyte ratio (NLR) were independent predictive factors for gastric cancer (GC). Our study was designed to prove the prognostic value of the combination of CRP and NLR (COC-NLR) in GC patients. Materials and methods: A total of 1,058 GC patients who underwent D2 resection from Sun Yat-Sen University Cancer Center between 2003 and 2013 were included. They were divided into three groups (low: NLR <= 2.5, CRP <= 6.1; medium: NLR >2.5, CRP <= 4.5; high: NLR >2.5, CRP >4.5 or NLR <= 2.5, CRP >6.1) by the random forest method. Survival analysis stratified by COC-NLR groups was performed. Results: The mean survival time for each group was: for the low group 75.44 months (95% CI: 72.48-78.40), the medium group 56.50 months (95% CI: 50.68-62.31), and the high group 38.65 months (95% CI: 34.51-42.97). The low group showed obviously better overall survival (OS) than other two groups (p<0.001). Survival analysis showed that COC-NLR had statistical significance in both univariate and multivariate analyses (p<0.01). Conclusion: This study showed that COC-NLR could work as an independent prognostic factor in GC and provide more accurate prediction than single NLR or CRP.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 34 条
[1]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[2]   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial [J].
Bang, Yung-Jue ;
Kim, Young-Woo ;
Yang, Han-Kwang ;
Chung, Hyun Cheol ;
Park, Young-Kyu ;
Lee, Kyung Hee ;
Lee, Keun-Wook ;
Kim, Yong Ho ;
Noh, Sang-Ik ;
Cho, Jae Yong ;
Mok, Young Jae ;
Kim, Yeul Hong ;
Ji, Jiafu ;
Yeh, Ta-Sen ;
Button, Peter ;
Sirzen, Florin ;
Noh, Sung Hoon .
LANCET, 2012, 379 (9813) :315-321
[3]   Systematic review and meta-analysis of enhanced recovery programmes in gastric cancer surgery [J].
Beamish, Andrew James ;
Chan, David Sheng Yi ;
Blake, Paul A. ;
Karran, Alexandra ;
Lewis, Wyn Griffith .
INTERNATIONAL JOURNAL OF SURGERY, 2015, 19 :46-54
[4]   Random forests [J].
Breiman, L .
MACHINE LEARNING, 2001, 45 (01) :5-32
[5]   Prediction of protein-protein interactions using random decision forest framework [J].
Chen, XW ;
Liu, M .
BIOINFORMATICS, 2005, 21 (24) :4394-4400
[6]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[7]   Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome [J].
Fairclough, Emily ;
Cairns, Eleanor ;
Hamilton, Jennifer ;
Kelly, Clive .
CLINICAL MEDICINE, 2009, 9 (01) :30-33
[8]   Estimation of the Youden index and its associated cutoff point [J].
Fluss, R ;
Faraggi, D ;
Reiser, B .
BIOMETRICAL JOURNAL, 2005, 47 (04) :458-472
[9]   The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: A literature review [J].
Gao, Yongyin ;
Huang, Dingzhi .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (04) :799-804
[10]   Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma [J].
Hu, Bo ;
Yang, Xin-Rong ;
Xu, Yang ;
Sun, Yun-Fan ;
Sun, Chao ;
Guo, Wei ;
Zhang, Xin ;
Wang, Wei-Min ;
Qiu, Shuang-Jian ;
Zhou, Jian ;
Fan, Jia .
CLINICAL CANCER RESEARCH, 2014, 20 (23) :6212-6222